NCT01554085View on ClinicalTrials.gov

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

PHASE1TerminatedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Hepatitis C, Chronic
Interventions
DRUG

ALS-002158

ALS-002158

DRUG

Placebo

placebo

Trial Locations (5)

4006

QPharm, Brisbane

5000

CMAX, Adelaide

6009

Linear Clinical Research Ltd, Perth

Unknown

Auckland Clinical Services, Auckland

Christchurch Clinical Studies Trust Ltd., Christchurch

Sponsors
All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Alios Biopharma Inc.

INDUSTRY

NCT01554085 - First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 | Biotech Hunter | Biotech Hunter